Stryker Revenue 2010-2024 | SYK
Stryker annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Stryker revenue for the quarter ending March 31, 2024 was $5.243B, a 9.73% increase year-over-year.
- Stryker revenue for the twelve months ending March 31, 2024 was $20.963B, a 10.61% increase year-over-year.
- Stryker annual revenue for 2023 was $20.498B, a 11.11% increase from 2022.
- Stryker annual revenue for 2022 was $18.449B, a 7.84% increase from 2021.
- Stryker annual revenue for 2021 was $17.108B, a 19.21% increase from 2020.
| Stryker Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $20,498 |
| 2022 | $18,449 |
| 2021 | $17,108 |
| 2020 | $14,351 |
| 2019 | $14,884 |
| 2018 | $13,601 |
| 2017 | $12,444 |
| 2016 | $11,325 |
| 2015 | $9,946 |
| 2014 | $9,675 |
| 2013 | $9,021 |
| 2012 | $8,657 |
| 2011 | $8,307 |
| 2010 | $7,320 |
| 2009 | $6,723 |
| Stryker Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $5,243 |
| 2023-12-31 | $5,815 |
| 2023-09-30 | $4,909 |
| 2023-06-30 | $4,996 |
| 2023-03-31 | $4,778 |
| 2022-12-31 | $5,202 |
| 2022-09-30 | $4,479 |
| 2022-06-30 | $4,493 |
| 2022-03-31 | $4,275 |
| 2021-12-31 | $4,701 |
| 2021-09-30 | $4,160 |
| 2021-06-30 | $4,294 |
| 2021-03-31 | $3,953 |
| 2020-12-31 | $4,262 |
| 2020-09-30 | $3,737 |
| 2020-06-30 | $2,764 |
| 2020-03-31 | $3,588 |
| 2019-12-31 | $4,131 |
| 2019-09-30 | $3,587 |
| 2019-06-30 | $3,650 |
| 2019-03-31 | $3,516 |
| 2018-12-31 | $3,796 |
| 2018-09-30 | $3,242 |
| 2018-06-30 | $3,322 |
| 2018-03-31 | $3,241 |
| 2017-12-31 | $3,471 |
| 2017-09-30 | $3,006 |
| 2017-06-30 | $3,012 |
| 2017-03-31 | $2,955 |
| 2016-12-31 | $3,157 |
| 2016-09-30 | $2,833 |
| 2016-06-30 | $2,840 |
| 2016-03-31 | $2,495 |
| 2015-12-31 | $2,715 |
| 2015-09-30 | $2,420 |
| 2015-06-30 | $2,432 |
| 2015-03-31 | $2,379 |
| 2014-12-31 | $2,618 |
| 2014-09-30 | $2,389 |
| 2014-06-30 | $2,363 |
| 2014-03-31 | $2,305 |
| 2013-12-31 | $2,468 |
| 2013-09-30 | $2,151 |
| 2013-06-30 | $2,212 |
| 2013-03-31 | $2,190 |
| 2012-12-31 | $2,338 |
| 2012-09-30 | $2,052 |
| 2012-06-30 | $2,106 |
| 2012-03-31 | $2,161 |
| 2011-12-31 | $2,215 |
| 2011-09-30 | $2,031 |
| 2011-06-30 | $2,046 |
| 2011-03-31 | $2,015 |
| 2010-12-31 | $1,995 |
| 2010-09-30 | $1,768 |
| 2010-06-30 | $1,758 |
| 2010-03-31 | $1,799 |
| 2009-12-31 | $1,834 |
| 2009-09-30 | $1,653 |
| 2009-06-30 | $1,634 |
| 2009-03-31 | $1,601 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $129.618B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
| Boston Scientific (BSX) | United States | $112.981B | 35.99 |
| Medtronic (MDT) | Ireland | $100.927B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.585B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
| ResMed (RMD) | United States | $28.121B | 26.40 |
| Terumo (TRUMY) | Japan | $24.403B | 34.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
| Baxter (BAX) | United States | $17.045B | 12.12 |
| Insulet (PODD) | United States | $14.134B | 62.67 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
| Demant (WILYY) | Denmark | $9.370B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.790B | 25.48 |
| BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
| Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Haemonetics (HAE) | United States | $4.215B | 20.79 |
| Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
| Neogen (NEOG) | United States | $3.386B | 32.56 |
| ICU Medical (ICUI) | United States | $2.893B | 25.54 |
| Envista Holdings (NVST) | United States | $2.858B | 11.79 |
| TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
| Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
| Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
| Warby Parker (WRBY) | United States | $1.592B | 0.00 |
| InMode (INMD) | Israel | $1.532B | 8.14 |
| AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
| Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.084B | 0.00 |
| Owens & Minor (OMI) | United States | $1.033B | 9.00 |
| National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
| BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
| Surmodics (SRDX) | United States | $0.599B | 37.54 |
| Quanterix (QTRX) | United States | $0.506B | 0.00 |
| ZimVie (ZIMV) | United States | $0.498B | 42.44 |
| Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Biote (BTMD) | United States | $0.463B | 10.67 |
| Jin Medical (ZJYL) | China | $0.403B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
| Zynex (ZYXI) | United States | $0.296B | 40.52 |
| MacroGenics (MGNX) | United States | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
| Omeros (OMER) | United States | $0.235B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
| Veru (VERU) | United States | $0.123B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.26 |
| Brainsway (BWAY) | Israel | $0.101B | 0.00 |
| InterCure (INCR) | Israel | $0.092B | 15.46 |
| Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
| MariMed (MRMD) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 14.90 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |